XML 28 R3.htm IDEA: XBRL DOCUMENT
v3.25.1

Award Timing Disclosure | 12 Months Ended |
--- | --- | ---
Dec. 31, 2024 | Feb. 23, 2024 USD ($) shares $ / shares
Award Timing Disclosures [Line Items] |  |
Award Timing MNPI Disclosure | Practices Related to the Grant of Certain Equity Awards The Company generally maintains a structured equity grant timing process designed to ensure compliance with applicable securities laws, corporate governance best practices, and the avoidance of material nonpublic information (“MNPI”) in granting equity awards. The Compensation Committee generally grants annual equity-based awards to our executive officers in February of each year, in connection with our annual compensation review and approval process, although the exact timing may change from year to year. Our Compensation Committee may also grant equity awards, including RSUs and stock options, at different times of the year for new hires and in connection with promotions, or grants made for retention or other purposes. Stock option exercise prices are set at the closing price of the Company’s common stock on the grant date, in accordance with the Company’s equity plan and applicable securities regulations. This process is designed to prevent any appearance of opportunistic grant timing and to ensure that equity awards are made in a manner that reflects long-term stockholder value creation. Our Compensation Committee does not grant equity awards in anticipation of the release of MNPI and we have not timed the disclosure of MNPI for the purpose of affecting the value of executive compensation. During 2024, the Company granted the following stock options to named executive officers during a period beginning four business days before and ending one business day after the filing of any Company periodic report on Form 10-Q or Form 10-K, or the filing or furnishing of any Company current report on Form 8-K (other than a current report on Form 8-K disclosing a material new option award grant under Item 5.02(e) of that form) that disclosed any MNPI:
Name |  | Grant date |  | Number of securities underlying the award |  | Exercise price of the award |  | Grant date fair value of the award |  | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information
Waleed H. Hassanein, M.D. |  |  |  | 2/23/2024 |  |  |  |  | 56,645 |  |  |  | $ | 83.14 |  |  |  |  | 3,040,613 |  |  |  |  | 6.70% |
Stephen Gordon |  |  |  | 2/23/2024 |  |  |  |  | 18,690 |  |  |  | $ | 83.14 |  |  |  |  | 1,003,249 |  |  |  |  | 6.70% |
Nicholas Corcoran |  |  |  | 2/23/2024 |  |  |  |  | 17,632 |  |  |  | $ | 83.14 |  |  |  |  | 946,458 |  |  |  |  | 6.70% |
Tamer Khayal, M.D. |  |  |  | 2/23/2024 |  |  |  |  | 18,690 |  |  |  | $ | 83.14 |  |  |  |  | 1,003,249 |  |  |  |  | 6.70% |
MNPI Disclosure Timed for Compensation Value | false |
Awards Close in Time to MNPI Disclosures, Table |
Name |  | Grant date |  | Number of securities underlying the award |  | Exercise price of the award |  | Grant date fair value of the award |  | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information
Waleed H. Hassanein, M.D. |  |  |  | 2/23/2024 |  |  |  |  | 56,645 |  |  |  | $ | 83.14 |  |  |  |  | 3,040,613 |  |  |  |  | 6.70% |
Stephen Gordon |  |  |  | 2/23/2024 |  |  |  |  | 18,690 |  |  |  | $ | 83.14 |  |  |  |  | 1,003,249 |  |  |  |  | 6.70% |
Nicholas Corcoran |  |  |  | 2/23/2024 |  |  |  |  | 17,632 |  |  |  | $ | 83.14 |  |  |  |  | 946,458 |  |  |  |  | 6.70% |
Tamer Khayal, M.D. |  |  |  | 2/23/2024 |  |  |  |  | 18,690 |  |  |  | $ | 83.14 |  |  |  |  | 1,003,249 |  |  |  |  | 6.70% |
Waleed H. Hassanein, M.D. [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Waleed H. Hassanein, M.D.
Underlying Securities | shares |  | 56,645
Exercise Price | $ / shares |  | $ 83.14
Fair Value as of Grant Date | $ |  | $ 3,040,613
Underlying Security Market Price Change |  | 6.7
Stephen Gordon [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Stephen Gordon
Underlying Securities | shares |  | 18,690
Exercise Price | $ / shares |  | $ 83.14
Fair Value as of Grant Date | $ |  | $ 1,003,249
Underlying Security Market Price Change |  | 6.7
Nicholas Corcoran [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Nicholas Corcoran
Underlying Securities | shares |  | 17,632
Exercise Price | $ / shares |  | $ 83.14
Fair Value as of Grant Date | $ |  | $ 946,458
Underlying Security Market Price Change |  | 6.7
Tamer Khayal, M.D. [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Tamer Khayal, M.D.
Underlying Securities | shares |  | 18,690
Exercise Price | $ / shares |  | $ 83.14
Fair Value as of Grant Date | $ |  | $ 1,003,249
Underlying Security Market Price Change |  | 6.7

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence D + Details
Name: | ecd_AwardExrcPrice
Namespace Prefix: | ecd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence E + Details
Name: | ecd_AwardGrantDateFairValue
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgDiscLineItems
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMnpiDiscTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence C + Details
Name: | ecd_AwardUndrlygSecuritiesAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence A + Details
Name: | ecd_AwardsCloseToMnpiDiscIndName
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_MnpiDiscTimedForCompValFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence F + Details
Name: | ecd_UndrlygSecurityMktPriceChngPct
Namespace Prefix: | ecd_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ecd_IndividualAxis=tmdx_WaleedHHassaneinMdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tmdx_StephenGordonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tmdx_NicholasCorcoranMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tmdx_TamerKhayalMdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |